Kenneth B. Wells, M.D., M.P.H. (Chair), is the director of the Center for Health Services and Society at the Jane and Terry Semel Institute for Neuroscience and Human Behavior of the University of California, Los Angeles (UCLA), and the David Weil Professor of Psychiatry and Biobehavioral Sciences at the UCLA David Geffen School of Medicine and the Department of Health Policy and Management in the Fielding School of Public Health. He is affiliated adjunct staff at the RAND Corporation and a staff psychiatrist at the West Los Angeles branch of the Department of Veterans Affairs. His research interests are in integrating evidence-based practices with community-partnered participatory research approaches to address behavioral health disparities and social determinants of health. He received his B.A. from Occidental College, his M.D. from the University of California, San Francisco, and his M.P.H. from UCLA. Dr. Wells is a member of the National Academy of Medicine.
Hortensia Amaro, Ph.D. (Vice Chair), is a Distinguished University Professor and a Senior Scholar on Community Health at the Herbert Wertheim College of Medicine and the Robert Stempel College of Public Health & Social Work at Florida International University. She previously served as an associate vice provost and the dean’s professor at the University of Southern California, a distinguished professor and an associate dean at the Northeastern University Bouvé College of Health Sciences, and a professor at the Boston University School of Public Health. Dr. Amaro founded five programs for the treatment of substance use disorders (SUDs) among disenfranchised minority women—including pregnant and postpartum women
and women returning from incarceration—in Boston. She served as the vice chair of the board of the Boston Public Health Commission and on review and advisory committees to the National Institutes of Health, the Substance Abuse and Mental Health Services Administration, and the Centers for Disease Control and Prevention and as a consultant on SUDs for the Department of State’s Latin America programs. Dr. Amaro’s research focuses on alcohol and drug use among adolescents and adults; treatment of SUD, mental health disorders, and trauma among minority women; alcohol and drug use among college populations; and the development and testing of gender-specific behavioral interventions for HIV/AIDS prevention. She received her Ph.D. in psychology from the University of California, Los Angeles. Dr. Amaro is a member of the National Academy of Medicine.
Gina Bryan, D.N.P., PMHCNS-BC, A.P.R.N., is a clinical professor and the director of the Post Graduate Psych-Mental Health Program at the University of Wisconsin–Madison School of Nursing. She teaches in the graduate nursing and pharmacy programs. In addition, Dr. Bryan maintains an active clinical practice in community psychiatry at Rock County Mental Health. She was a partner on a Substance Abuse and Mental Health Services Administration Screening, Brief Intervention, and Referral to Treatment training grant. Dr. Bryan also serves on the Wisconsin Commission on Substance Abuse Treatment Delivery to research hub-and-spoke delivery models for opioid treatment and identify key implementation considerations. Her scholarly interests are currently focused on novel health care provider collaborations to improve access to medications for substance use disorders. Dr. Bryan earned her B.S.N., M.S., and D.N.P. from the University of Wisconsin–Madison.
Karen Cropsey, Psy.D., is a licensed clinical psychologist and the Conaster Turner Endowed Professor of Psychiatry at The University of Alabama at Birmingham School of Medicine. Dr. Cropsey is also a certified forensic evaluator. She was previously the director of mental health for the Mississippi Department of Corrections. Dr. Cropsey’s research interests include treatment interventions for correctional and other disenfranchised populations with substance use disorders (SUDs), with a particular focus on opioid treatment interventions. She has conducted several studies investigating the treatment of opioid dependence in criminal justice and HIV-infected populations. Her laboratory conducts clinical research trials on SUD treatment, developing and testing novel therapeutics, behavioral techniques, and technology interventions. This includes a study on training and distributing naloxone kits in the community. Dr. Cropsey completed her M.S. at the University of Wisconsin–Madison and her Psy.D. at Indiana State University.
Marcela Horvitz-Lennon, M.D., M.P.H., is a senior physician scientist at the RAND Corporation, a core faculty member of the Pardee RAND Graduate School, and an associate professor of psychiatry (part time) at Harvard Medical School. She is also a practicing psychiatrist at Cambridge HealthAlliance. Much of her research is on the quality and value of health care received by adults with serious mental illnesses, with a focus on public payers. Dr. Horvitz-Lennon has conducted research on health care program evaluation; racial/ethnic and geographic disparities in care; Medicaid and federal health care policy; underuse and overuse of mental health interventions; integration of physical and mental health care; diffusion of mental health innovations; and global mental health. She has been involved in evaluations of Substance Abuse and Mental Health Services Administration programs, including the primary and behavioral health care integration grant program and the mental health block grant set-aside program. Dr. Horvitz-Lennon earned her M.D. in Chile and her M.P.H. at Johns Hopkins University.
Sandeep Kapoor, M.D., is an assistant professor of medicine, emergency medicine, and science education at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, assistant vice president of addiction services for the Northwell Health Emergency Medicine Service Line, and director of Screening, Brief Intervention, and Referral to Treatment (SBIRT) at Northwell Health. As a member of the Northwell Health Opioid Management Steering Committee, which is charged to collate a community of solutions to address the prevalent opioid epidemic, Dr. Kapoor leads interdisciplinary efforts to unify system-wide substance use screening protocols, deliver workforce training, scale NAL-SAT (Naloxone Saturation Campaign), and develop strategies for school, community, and employee engagement. He is the recipient of the 2020 Northwell Health President’s Award for Leadership and received the 2020 Outstanding Mentor Award by the American Academy of Child & Adolescent Psychiatry. Dr. Kapoor received his M.D. from University College Dublin School of Medicine and Medical Sciences. He has previously served on a National Academies planning committee for a workshop on Facilitating the Integration of Firearm Injury Prevention into Healthcare.
Raymond C. Love, Pharm.D., is a professor of pharmacy and psychiatry at the University of Maryland School of Pharmacy, where he is also vice chair of Collaborative Initiatives for the Department of Pharmacy Practice and Science. He directs the State of Maryland Mental Health Pharmacy Program, coordinates the Maryland Statewide Pharmacy and Therapeutics Committee, and participates in planning mental health pharmacy services and systems at various levels of state government. This work has resulted in
introducing a number of innovations, including clinical pharmacy services, psychiatric pharmacotherapy, statewide data tracking, drug use analysis, educational programs, and community partnerships. In addition, Dr. Love co-directs the Center for Addiction Research, Education, and Service at the University of Maryland. He earned his Pharm.D. from the University of Maryland.
Rosalie Pacula, Ph.D., is professor and the Elizabeth Garrett Chair in Health Policy, Economics and Law in the Sol Price School of Public Policy and Senior Fellow with the University of Southern California (USC) Leonard D. Schaeffer Center for Health Policy & Economics. For 15 years prior to joining USC, she served as co-director of RAND’s Drug Policy Research Center. Her research focuses on issues related to illegal or imperfect markets (health care markets, insurance markets, markets for addictive goods), the measurement of these markets, and the impact of policies on the behavior of actors in these markets. Specifically, she studies the effects of opioid policies on opioid related harm and misuse, the development of improved data and methods for assessing the opioid crisis, the policies targeting it, and its short- and long-term effects on communities. She is the current president of the International Society for the Study of Drug Policy and serves on the Centers for Disease Control and Prevention’s National Injury Prevention’s Board of Scholarly Counsellors. She received an M.A. and a Ph.D. in economics from Duke University.
José A. Pagán, Ph.D., is chair and professor of the Department of Public Health Policy and Management at the New York University (NYU) School of Global Public Health. He is also chair of the board of directors of NYC Health + Hospitals, the largest public health care system in the United States. He formerly served as chair of the National Advisory Committee of the Robert Wood Johnson Foundation’s Health Policy Research Scholars and was a member of the Board of Directors of the Interdisciplinary Association for Population Health Science and the American Society of Health Economists. He has led research, implementation, and evaluation projects on the redesign of health care delivery and payment systems. His areas of focus are in population health management, health care payment and delivery system reform, and the social determinants of health. Dr. Pagán received his Ph.D. in economics from the University of New Mexico.
Sharon Reif, Ph.D., is a professor in social policy and management at Brandeis University. She is also the deputy director of the university’s Institute for Behavioral Health. Dr. Reif conducts health services research using survey, interview, and quantitative methods and secondary data analysis to address treatment and quality issues for people with substance use
disorders (SUDs). Her research interests include medications for treating addiction, treatment of opioid use disorders, implementation of Screening, Brief Intervention and Referral to Treatment in a community organization serving low-income young adults, and the impact of health reform and parity on behavioral health service delivery, quality of care, and financing and access to care. Her work has included collaborations with community organizations, communities more broadly, and states, with the use of national datasets. Dr. Reif has prepared a white paper on the opioid crisis and published systematic reviews in the areas of peer support, residential treatment, and housing for people with SUDs. She received her Ph.D. from Brandeis University.
Gery Ryan, Ph.D., is professor of health system science at the Kaiser Permanente Bernard J. Tyson School of Medicine. He previously served as assistant dean of academics at the Pardee RAND Graduate School in Policy Analysis and was a senior behavioral scientist at the RAND Corporation. Trained as a medical anthropologist and methodologist, his research spans mental and physical health and includes work on HIV/AIDS, homelessness, depression, serious mental illness, childhood illnesses, obesity, social networks, human trafficking, and complementary and alternative medicine. As a methodologist and evaluator, he specializes in the integration of qualitative and quantitative methodologies; designing, implementing, and assessing complex system interventions; and quality-improvement projects. He received his M.A. and Ph.D. in cultural anthropology from the University of Florida.
NATIONAL ACADEMY OF MEDICINE FELLOW
Ruchi Fitzgerald, M.D., FAAFP, is the James C. Puffer, MD/American Board of Family Medicine Fellow to the National Academy of Medicine. She is a family physician and an addiction medicine physician. She is the Service Chief of Inpatient Addiction Medicine at PCC Community Wellness, a federally qualified health center system that serves the West Side of Chicago. Dr. Fitzgerald is an assistant professor in the Departments of Family Medicine and Psychiatry and Behavioral Sciences at Rush University, as well as the associate program director of the Rush Addiction Medicine Fellowship. She completed the addiction medicine fellowship at Rush University in 2020. She is a graduate of the University of Michigan Medical School and completed her family medicine residency in 2012 with the Montana Family Medicine Residency. Dr. Fitzgerald developed an interest in provision of care for underserved populations and those affected by substance use disorders during her residency. Her love for teaching medical students and family practice residents developed in Montana while she was a community
faculty physician with the Montana Family Medicine Residency Program. Dr. Fitzgerald also has extensive experience in telemedicine. During her fellowship, Dr. Fitzgerald worked with the addiction medicine faculty to create RISE-MD (Rush Integrative Substance Use Disorder Education for Medical Doctors), an educational initiative in Rush Medical College that focuses on eliminating stigma while promoting evidence-based treatment of substance use disorders in the next generation of physicians. She has worked with the American Society of Addiction Medicine and the Illinois Society of Addiction Medicine on key advocacy and policy initiatives related to substance use disorders. Dr. Fitzgerald is also an active member of the Federation of State Physician Health Programs and is an advocate for physician health and wellness.